Clinical Trials Directory

Trials / Completed

CompletedNCT01357304

10 Prescriptions an Hour. Group Treatment and Physical Activity Referral in a Primary Health Care Setting

Randomized Controlled Trial of Group Treatment With Physical Activity Referral in a Primary Health Care Setting

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
105 (actual)
Sponsor
Region Skane · Academic / Other
Sex
All
Age
18 Years – 79 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine the effects of group treatment including physical activity referral (PAR) on level of physical activity and quality of life in patients diagnosed with type 2 diabetes and/or hypertension in a primary health care setting

Detailed description

A sedentary lifestyle and low levels of physical activity in populations are major health problems today and contribute substantially to poor health and diseases such as type 2 diabetes and hypertension. An increased and systematic effort to increase physical activity in the Swedish population in general, and in patients with type 2 diabetes/hypertension in particular, is important. Written prescriptions of physical activity with follow-up (i.e., PAR), is a cost-efficient way to increase physical activity in individuals. The aim of this trial is to study whether physical activity is increased by a group method involving PARs in patients with hypertension and/or type 2 diabetes compared with a control group that receives usual care in the same primary care setting. Follow-up will be performed at 6 and 12 months. This trial is being conducted to determine whether it is possible to offer PARs to more patients in a way that requires less effort and resources. The intervention in this study requires 10 minutes of a health care worker's time per patient during a 6-month period. Each patient requires 100 minutes with an instructor who oversees the group intervention. Group treatment is given 3 weeks after baseline and at 6 months. Follow-up at 12 months involves data collection, but no intervention. An empowerment process, with the 5-A-model as framework, will be used in the clinical intervention. All participants will be required to fill in questionnaires and wear an ActiGraph GTM1/GTM3 for 7 days at baseline and at 6 and 12 months.

Conditions

Interventions

TypeNameDescription
BEHAVIORALGroup treatment and PARGroup treatment (8-12 patients per group) involving an empowerment-based process and the 5-A model and including PAR. Two group sessions, 6 months apart. The estimated total time for both group sessions together is 100 minutes.

Timeline

Start date
2011-03-01
Primary completion
2012-06-01
Completion
2012-09-01
First posted
2011-05-20
Last updated
2012-11-27

Locations

1 site across 1 country: Sweden

Source: ClinicalTrials.gov record NCT01357304. Inclusion in this directory is not an endorsement.